Boost Your Gut Health: How Fiber and Microbiome Diversity Reduce Disease Risk

Current medical guidelines focus not only on acute care but also on long-term prevention.

A Healthy Gut Flora as a Shield

An balanced microbiome is the key to gut health. Expert reports reveal that high diversity in bacterial strains and a balanced ratio of microorganisms can significantly reduce the risk of diseases such as obesity, diabetes, and cancer.

Experts recommend a fiber-rich diet. This approach fosters a diverse colonization of bacteria in the gut. However, medical professionals view commercial microbiome tests critically as these analyses can range from $90 to $450 but often provide limited clinical benefits for specific treatment decisions.

New Standards for Gastroenterology

The German Society for Internal Medicine (DGIM) published five new recommendations in spring 2025. The guidelines from the “Smart Decisions” initiative aim to prevent both over- and under-treatment.

Would you also like to improve your gut health? A balanced microbiome can reduce the risk of obesity, diabetes, and cancer. In this free guide, you will learn how to strengthen your gut flora through a fiber-rich diet in three simple steps. Request your free guide now

Highlights of the current updates include diagnostics of irritable bowel syndrome, screening for Barrett’s esophagus, and addressing malnutrition in cancer patients. In total, the directory now includes over 170 recommendations as guidance for physicians.

From Diagnosis to Prevention

Diverticulitis—a condition involving inflammation of pouches in the intestinal wall—requires a nuanced treatment approach. Medical professionals emphasize that the earlier causes and symptoms are identified, the better complications can be avoided.

Commercial microbiome tests, often lacking clinical value, may cost between $90 and $450. Instead, focus on naturally promoting your gut diversity. Our guide provides insights on how to do so. Secure your guide to promoting microbiome health

On August 19, 2026, Viersen’s AKH will inform about the latest treatment standards. Prof. Dr. Nadja Lehwald-Tywuschik, Chief Physician for Visceral and General Surgery, will explain the different phases of the illness—from pain-relief therapies in acute stages to surgical options and preventive measures against recurrence of inflammation.

The goal: to enhance care quality by linking clinical guidelines with targeted patient education, empowering patients in their journey to health.